JP2006149406A5 - - Google Patents

Download PDF

Info

Publication number
JP2006149406A5
JP2006149406A5 JP2006034592A JP2006034592A JP2006149406A5 JP 2006149406 A5 JP2006149406 A5 JP 2006149406A5 JP 2006034592 A JP2006034592 A JP 2006034592A JP 2006034592 A JP2006034592 A JP 2006034592A JP 2006149406 A5 JP2006149406 A5 JP 2006149406A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
amino acid
set forth
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006034592A
Other languages
English (en)
Japanese (ja)
Other versions
JP4324596B2 (ja
JP2006149406A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2006149406A publication Critical patent/JP2006149406A/ja
Publication of JP2006149406A5 publication Critical patent/JP2006149406A5/ja
Application granted granted Critical
Publication of JP4324596B2 publication Critical patent/JP4324596B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006034592A 1995-09-01 2006-02-10 結核の免疫治療および診断のための化合物および方法 Expired - Fee Related JP4324596B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52343695A 1995-09-01 1995-09-01
US53363495A 1995-09-22 1995-09-22
US62087496A 1996-03-22 1996-03-22
US65968396A 1996-06-05 1996-06-05
US68057496A 1996-07-12 1996-07-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP51146497A Division JP4382160B2 (ja) 1995-09-01 1996-08-30 結核の免疫治療および診断のための化合物および方法

Publications (3)

Publication Number Publication Date
JP2006149406A JP2006149406A (ja) 2006-06-15
JP2006149406A5 true JP2006149406A5 (OSRAM) 2007-06-14
JP4324596B2 JP4324596B2 (ja) 2009-09-02

Family

ID=27541835

Family Applications (5)

Application Number Title Priority Date Filing Date
JP51146497A Expired - Lifetime JP4382160B2 (ja) 1995-09-01 1996-08-30 結核の免疫治療および診断のための化合物および方法
JP2006034592A Expired - Fee Related JP4324596B2 (ja) 1995-09-01 2006-02-10 結核の免疫治療および診断のための化合物および方法
JP2006034593A Expired - Lifetime JP4324597B2 (ja) 1995-09-01 2006-02-10 結核の免疫治療および診断のための化合物および方法
JP2007077972A Expired - Fee Related JP4324618B2 (ja) 1995-09-01 2007-03-23 結核の免疫治療および診断のための化合物および方法
JP2009094008A Ceased JP2009159982A (ja) 1995-09-01 2009-04-08 結核の免疫治療および診断のための化合物および方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP51146497A Expired - Lifetime JP4382160B2 (ja) 1995-09-01 1996-08-30 結核の免疫治療および診断のための化合物および方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2006034593A Expired - Lifetime JP4324597B2 (ja) 1995-09-01 2006-02-10 結核の免疫治療および診断のための化合物および方法
JP2007077972A Expired - Fee Related JP4324618B2 (ja) 1995-09-01 2007-03-23 結核の免疫治療および診断のための化合物および方法
JP2009094008A Ceased JP2009159982A (ja) 1995-09-01 2009-04-08 結核の免疫治療および診断のための化合物および方法

Country Status (23)

Country Link
EP (5) EP0851927B1 (OSRAM)
JP (5) JP4382160B2 (OSRAM)
KR (1) KR100433750B1 (OSRAM)
CN (1) CN1117149C (OSRAM)
AT (5) ATE337399T1 (OSRAM)
AU (1) AU727602B2 (OSRAM)
BR (2) BR9612997B1 (OSRAM)
CA (3) CA2684425A1 (OSRAM)
CY (2) CY2570B1 (OSRAM)
CZ (3) CZ300953B6 (OSRAM)
DE (4) DE69636487T2 (OSRAM)
DK (4) DK1398379T3 (OSRAM)
ES (4) ES2324529T3 (OSRAM)
HU (2) HU227778B1 (OSRAM)
IL (1) IL123506A (OSRAM)
MX (1) MX9801638A (OSRAM)
NO (4) NO324372B1 (OSRAM)
NZ (1) NZ319377A (OSRAM)
PL (1) PL186774B1 (OSRAM)
PT (4) PT1203817E (OSRAM)
SI (1) SI0851927T1 (OSRAM)
TR (5) TR200403064T2 (OSRAM)
WO (1) WO1997009428A2 (OSRAM)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2501135Y2 (ja) 1989-06-10 1996-06-12 エヌティエヌ株式会社 摩擦式無段変速機
JP2501911B2 (ja) 1989-08-15 1996-05-29 日産自動車株式会社 トロイダル型無段変速機
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6641814B1 (en) 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
EP0934415A2 (en) * 1996-10-11 1999-08-11 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6350456B1 (en) 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6627198B2 (en) 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
DE69838268T2 (de) * 1997-04-02 2008-05-08 Statens Serum Institut Immonologisch aktiven, neuen Polypeptidefragmenten
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US6555653B2 (en) * 1997-05-20 2003-04-29 Corixa Corporation Compounds for diagnosis of tuberculosis and methods for their use
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
AU8123898A (en) * 1997-07-16 1999-02-10 Institut Pasteur A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as metho ds usingthe same
EP1484405A1 (en) * 1997-11-10 2004-12-08 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
NZ504951A (en) * 1997-11-10 2001-06-29 Statens Seruminstitut Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
CZ302870B6 (cs) * 1998-04-07 2011-12-28 Corixa Corporation Polynukleotid, polypeptid, farmaceutický prostredek, vakcínový prostredek a jejich použití k lécbe a prevenci infekce tuberkulózou
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
DE69941545D1 (de) * 1998-11-04 2009-11-26 Isis Innovation Tuberkulose diagnose test
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
AU2594500A (en) * 1998-12-24 2000-07-31 Corixa Corporation Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
ES2326257T3 (es) 1999-05-04 2009-10-06 The University Of Medicine And Dentistry Of New Jersey Proteinas expresadas por mycobacterium tuberculosis y no por bcg y su utilizacion como reactivos diagnosticos y vacunas.
US7009042B1 (en) * 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
WO2001062893A2 (en) 2000-02-25 2001-08-30 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
AU6867801A (en) 2000-06-20 2002-01-02 Corixa Corp Fusion proteins of mycobacterium tuberculosis
WO2003070187A2 (en) 2002-02-15 2003-08-28 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
FI119445B (fi) * 2004-10-29 2008-11-14 Waertsilae Finland Oy Polttomoottorin polttoaineen syöttöjärjestelmän paineen värähtelyn vaimennin
KR101255870B1 (ko) 2004-11-16 2013-04-17 아에라스 글로벌 티비 백신 파운데이션 재조합 바이러스 벡터를 포함하는 다가 백신
EP1877426B1 (en) 2005-04-29 2012-02-01 GlaxoSmithKline Biologicals SA Method for preventing or treating m tuberculosis infection
FR2952058B1 (fr) * 2009-10-29 2013-10-04 Centre Nat Rech Scient Procede de ligation native de polypeptides
US8932600B2 (en) 2010-01-27 2015-01-13 Glaxosmithkline Biologicals S.A. Modified tuberculosis antigens
KR20190022897A (ko) 2010-12-14 2019-03-06 글락소스미스클라인 바이오로지칼즈 에스.에이. 미코박테리움 항원성 조성물
FR2971509B1 (fr) * 2011-02-16 2013-02-22 Centre Nat Rech Scient Procede de preparation de peptides par assemblage de multiples fragments peptidiques
CN103290030A (zh) * 2012-02-23 2013-09-11 上海交通大学 一种结核分枝杆菌标志物HtdY的重组蛋白及其制备方法和临床应用
SG11201406592QA (en) * 2012-05-04 2014-11-27 Pfizer Prostate-associated antigens and vaccine-based immunotherapy regimens
BR112016023040A2 (pt) * 2014-04-04 2018-01-16 Vestaron Corporation processo para aumentar a atividade ou toxicidade de um peptídeo
GB201513176D0 (en) 2015-07-27 2015-09-09 Glaxosmithkline Biolog Sa Novel methods for inducing an immune response
FR3048286B1 (fr) * 2016-02-26 2021-01-22 Omunis Peptides immunogenes et leur utilisation
CN107304231B (zh) * 2016-04-18 2021-01-01 华中农业大学 一种结核分枝杆菌融合蛋白及应用
GB201614485D0 (en) * 2016-08-25 2016-10-12 Univ Oxford Innovation Ltd Immunogenic composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
US4876089A (en) * 1984-09-06 1989-10-24 Chiron Corporation Feline leukemia virus protein vaccines
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine

Similar Documents

Publication Publication Date Title
JP2006149406A5 (OSRAM)
JP2006187292A5 (OSRAM)
JP2008529558A5 (OSRAM)
JP2008530245A5 (OSRAM)
CA2230885A1 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
ES2612741T3 (es) Proteínas de fusión proteína n de un virus de la familia paramyxoviridae-proteína de interés
JP2006501825A5 (OSRAM)
JP2002503683A5 (OSRAM)
JP2002510494A5 (OSRAM)
ES2278436T3 (es) Antigenos de estreptococos del grupo b.
JP2008536483A5 (OSRAM)
JP2004511201A5 (OSRAM)
JP2010500399A5 (OSRAM)
JP2009268467A5 (OSRAM)
BRPI0707154B8 (pt) composição de vacina
JP2013517783A5 (OSRAM)
JP2010529860A5 (OSRAM)
JP2010532656A5 (OSRAM)
JP2003500040A5 (OSRAM)
JP2008507298A5 (OSRAM)
JP2004531242A5 (OSRAM)
JP2011528222A5 (OSRAM)
JPWO2021219897A5 (OSRAM)
JP2012516140A5 (OSRAM)
JP2008545393A5 (OSRAM)